By Alexander Marrow LONDON, Feb 18 (Reuters) - Nestle and Danone face investor pressure to spell out the financial impact of ...

The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...

Fourth-quarter sales topped estimates as protein demand strengthened, while infant formula recalls could trim first-quarter net sales by 0.5% to 1%.

Lactalis and Danone have become the latest companies to halt sales of certain infant formulas because of a problem with one of the raw materials. Infant formula and follow-on formulas were first ...

French firms Danone and Nestlé saw a continued plunge in their share prices on Wednesday after a safety crisis involving baby formula. At around midday in Europe, Danone shares were down 0.48%, while ...

Divestitures in Q1-2024 indicate that management continues to execute its “Renew Danone” plan, with a primary focus still on internal reorganization. Net income has been battered by extraordinary ...

Danone is undergoing a transformation with positive results, showing potential for a 13-16% annualized RoR. Danone remains an underperforming stock with a 2x variance compared to the market. Despite ...

Danone is preparing litigation against kefir maker – and takeover target – Lifeway Foods, alleging the business broke a shareholder agreement between the two companies. An investor in Lifeway since ...